---
document_datetime: 2023-09-21 19:51:13
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/infanrix-hexa-epar-all-authorised-presentations_en.pdf
document_name: infanrix-hexa-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.319845
conversion_datetime: 2025-12-22 10:03:58.613341
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented)n ame Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/00/152/001   | Infanrix hexa   | -- 1   | Powder and suspension for suspension for injection   | Intramuscular use   | powder: vial (glass); suspension: pre- filled syringe (glass)   | suspension: 0.5 ml   | 1 vial + 1 pre- filled syringe without needle                                   |
|-------------------|-----------------|--------|------------------------------------------------------|---------------------|-----------------------------------------------------------------|----------------------|---------------------------------------------------------------------------------|
| EU/1/00/152/002   | Infanrix hexa   | -- 1   | Powder and suspension for suspension for injection   | Intramuscular use   | powder: vial (glass); suspension: pre- filled syringe (glass)   | suspension: 0.5 ml   | 10 vials + 10 prefilled syringes without needles                                |
| EU/1/00/152/005   | Infanrix hexa   | -- 1   | Powder and suspension for suspension for injection   | Intramuscular use   | powder: vial (glass); suspension: pre- filled syringe (glass)   | suspension: 0.5 ml   | 1 vial + 1 pre- filled syringe + 2 needles                                      |
| EU/1/00/152/006   | Infanrix hexa   | -- 1   | Powder and suspension for suspension for injection   | Intramuscular use   | powder: vial (glass); suspension: pre- filled syringe (glass)   | suspension: 0.5 ml   | 10 vials + 10 pre-filled syringes + 20 needles                                  |
| EU/1/00/152/021   | Infanrix hexa   | -- 1   | Powder and suspension for suspension for injection   | Intramuscular use   | powder: vial (glass); suspension: pre- filled syringe (glass)   | suspension: 0.5 ml   | 50 (5 X 10) vials + 50 (5 X 10) pre-filled syringes without needles (multipack) |

## \\_ \\_1  After reconstitution, 1 dose (0.5 ml) contains:

| Diphtheria toxoid, adsorbed                                   | ≥ 30 IU   |
|---------------------------------------------------------------|-----------|
| Tetanus toxoid, adsorbed                                      | ≥ 40 IU   |
| Pertussis toxoid, adsorbed                                    | 25 µg     |
| Filamentous haemagglutinin, adsorbed                          | 25 µg     |
| Pertactin, adsorbed                                           | 8 µg      |
| Recombinant hepatitis B surface antigen (S protein), adsorbed | 10 µg     |
| Inactivated type 1 poliovirus                                 | 40 DU     |
| Inactivated type 2 poliovirus                                 | 8 DU      |
| Inactivated type 3 poliovirus                                 | 32 DU     |

<div style=\"page-break-after: always\"></div>

Conjugate of Haemophilus influenzae type b capsular polysaccharide (PRP) 10 µg and tetanus toxoid (T), adsorbed (PRP-T) Approximately 25 µg